Get the tools used by (smart)2 investors.
SP500 0.1%DOW -1.4%FTSE 100 0.1%NIKKEI 1.3%OIL 2.5%GOLD -0.4%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Cash Flow to Liabilities for Aquestive Therapeutics Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

AQST: Aquestive Therapeutics Inc

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seiz...

- USD
Price
– USD
Fair Value
–
Upside
- - -
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Aquestive Therapeutics Inc's Cash Flow to Liabilities:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024-80.0%-60.0%-40.0%-20.0%0.0%
Performance Summary
  • Aquestive Therapeutics's latest twelve months cash flow to liabilities is -22.0%
  • Aquestive Therapeutics's cash flow to liabilities for fiscal years ending December 2020 to 2024 averaged -20.8%.
  • Aquestive Therapeutics's operated at median cash flow to liabilities of -22.0% from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Aquestive Therapeutics's cash flow to liabilities peaked in December 2023 at -3.8%.
  • Aquestive Therapeutics's cash flow to liabilities hit its 5-year low in December 2020 of -46.4%.
  • Aquestive Therapeutics's cash flow to liabilities decreased in 2024 (-22.0%, +484.7%) and increased in 2020 (-46.4%, -37.8%), 2021 (-25.8%, -44.4%), 2022 (-6.1%, -76.2%), and 2023 (-3.8%, -38.8%).

How does Aquestive Therapeutics's Cash Flow to Liabilities benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Aquestive Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Aquestive Therapeutics Cash Flow to Liabilities Benchmarks
NameTickerCash Flow to Liabilities
Talphera IncNASDAQGM:TLPH-153.5%
HealthcareSECTOR:HLTH.US-53.3%
Aquestive Therapeutics IncNASDAQGM:AQST-22.0%
Avenir Wellness Solutions IncOTCPK:AVRW-11.8%
Cumberland Pharmaceuticals IncNASDAQGS:CPIX-1.2%
Indivior PLCNASDAQGS:INDV1.3%
Bausch Health Companies IncNYSE:BHC5.9%
ANI Pharmaceuticals IncNASDAQGM:ANIP9.8%
Assertio Therapeutics IncNASDAQCM:ASRT16.9%
Collegium Pharmaceutical IncNASDAQGS:COLL17.2%
Pacira Pharmaceuticals IncNASDAQGS:PCRX25.6%
Supernus Pharmaceuticals IncNASDAQGM:SUPN49.9%

Metric Usage: Cash Flow to Liabilities

Hide this widget
ocf_to_liabilities
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Cash Flow to Liabilities in the risk category include:

  • Current Ratio - A ratio that compares a company's current total assets to its current total liabilities.
  • Total Debt / Total Assets - A ratio that measures a company's total debt as a percentage of total assets.
  • Realized Volatility (1y) - Realized volatility (also known as rolling volatility) over the last one year.
  • Beneish M-Score - A statistical score that uses financial ratios to identify whether a company has manipulated its earnings
View Full List

Search for metric or datapoint

Cash Flow to Liabilities

A ratio that measures the amount of operating cash flow a firm generates on each dollar of total liabilities.

Definition of Cash Flow to Liabilities

Hide this widget
A ratio that measures the amount of operating cash flow a firm generates on each dollar of total liabilities.

Sector Benchmark Analysis

All rights reserved. Terms Of Use